PMID- 34865325 OWN - NLM STAT- MEDLINE DCOM- 20211207 LR - 20211214 IS - 1000-0607 (Print) IS - 1000-0607 (Linking) VI - 46 IP - 11 DP - 2021 Nov 25 TI - [Electroacupuncture at "Zusanli"(ST36) ameliorates tau hyperphosphorylation in pancreas and hippocampus of diabetic rats]. PG - 901-6 LID - 10.13702/j.1000-0607.200921 [doi] AB - OBJECTIVE: To observe the effect of electroacupuncture (EA) at "Zusanli"(ST36) on the phosphorylated tau levels in pancreas and hippocampus of type 2 diabetes mellitus (T2DM) rats,so as to explore the underlying mechanism of EA in diabetic demention rats. METHODS: Forty-eight male Sprague-Dawley rats were randomly divided into control, model and EA groups, with 16 rats in each group. The T2DM model was established by 6 weeks of high-fat, high-sugar diet as well as intrape-ritoneal injection of streptozocin (STZ) solution (35 mg/kg). After that, EA (2 Hz, 0.1 mA) was applied to unilateral "Zusanli"(ST36) for 30 min, once a day, 6 times a week for 4 weeks. The survival rate was recorded every week, and the fasting blood glucose (FBG) was detected on the 1st, 6th and 11th week. The level of serum insulin (INS) was measured by using ELISA. The morphological structure of pancreas islet was observed by H.E. staining. The expressions of phosphorylated tau at the sites of Ser 396 (pS396) and Thr 231 (pT231), total tau (Tau5), phosphorylated glycogen synthase kinase-3beta (pGSK-3beta) and total glycogen synthase kinase-3beta (GSK-3beta) in pancreas and hippocampus were detected by Western blot. The expression and distribution of pS396 and pT231 in pancreas and hippocampus were assayed with immunohistochemistry. RESULTS: Compared with the control group, the survival rate presented a significant decline, the contents of FBG and INS were obviously higher(P<0.01), and the structure of the pancreas islet appeared shrunken, obscure and disordered in the model group. Furthermore, the levels of pS396, pT231 in pancreas and hippocampus were obviously higher in the model group(P<0.01),while the level of pGSK-3beta in pancreas and hippocampus was significantly lower in the model group(P<0.01). In comparison with the model group, the survival rate of EA group was higher. Following 4 weeks' interventions, the enhanced levels of tau phosphorylation and GSK-3beta activity in pancreas and hippocampus were partly reversed in the EA group compared to the model group(P<0.05,P<0.01). CONCLUSION: EA at ST36 can reduce the level of tau phosphorylation via regulating the activity of GSK-3beta in the pancreas and hippocampus of T2DM rats, which may be related with the effect of EA on the brain function in T2DM rats. FAU - Yuan, Fang AU - Yuan F AD - College of Basic Medicine, Hubei University of Chinese Medicine, Wuhan 430065, China. FAU - Hong, Xiao-Ping AU - Hong XP AD - College of Basic Medicine, Hubei University of Chinese Medicine, Wuhan 430065, China. FAU - Duan, Yan-Jun AU - Duan YJ AD - College of Basic Medicine, Hubei University of Chinese Medicine, Wuhan 430065, China. FAU - Chen, Jiao-Rong AU - Chen JR AD - College of Basic Medicine, Hubei University of Chinese Medicine, Wuhan 430065, China. FAU - Han, Yong-Ming AU - Han YM AD - College of Basic Medicine, Hubei University of Chinese Medicine, Wuhan 430065, China. LA - chi PT - Journal Article PL - China TA - Zhen Ci Yan Jiu JT - Zhen ci yan jiu = Acupuncture research JID - 8507710 RN - EC 2.7.11.1 (Glycogen Synthase Kinase 3 beta) SB - IM MH - Animals MH - *Diabetes Mellitus, Experimental/genetics/therapy MH - *Diabetes Mellitus, Type 2 MH - *Electroacupuncture MH - Glycogen Synthase Kinase 3 beta/genetics MH - Hippocampus MH - *Islets of Langerhans MH - Male MH - Rats MH - Rats, Sprague-Dawley OTO - NOTNLM OT - Diabetes OT - Electroacupuncture OT - Hippocampus OT - Pancreas OT - Tau phosphorylation EDAT- 2021/12/06 06:00 MHDA- 2021/12/15 06:00 CRDT- 2021/12/05 21:59 PHST- 2021/12/05 21:59 [entrez] PHST- 2021/12/06 06:00 [pubmed] PHST- 2021/12/15 06:00 [medline] AID - 10.13702/j.1000-0607.200921 [doi] PST - ppublish SO - Zhen Ci Yan Jiu. 2021 Nov 25;46(11):901-6. doi: 10.13702/j.1000-0607.200921.